Results 221 to 230 of about 86,566 (299)

Agreement between an in‐house replication competent and a reference replication defective recombinant virus assay for measuring phenotypic resistance to HIV‐1 protease, reverse transcriptase, and integrase inhibitors

Journal of clinical laboratory analysis (Print), 2018
F. Saladini, Alessia Giannini, A. Boccuto, I. Vicenti, M. Zazzi   +4 more
semanticscholar   +1 more source

BIKSWITCH Study: Effectiveness and Safety of Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) From Therapies Not Based on Integrase Inhibitors in Virologically Suppressed HIV-Infected Patients. [PDF]

AIDS Res Treat
Pérez-Calvo F, Jover-Diaz F, Delgado-Sánchez E, Peris-García J, Bernabéu-Martínez MÁ.   +4 more
europepmc   +1 more source

Pharmacophore‐Based Discovery of Small‐Molecule Inhibitors of Protein–Protein Interactions between HIV‐1 Integrase and Cellular Cofactor LEDGF/p75

, 2009
Laura De Luca, Maria Letizia Barreca, Stefania Ferro, Frauke Christ, Nunzio Iraci, Rosaria Gitto, Anna Maria Monforte, Zeger Debyser, Alba Chimirri   +8 more
openalex   +2 more sources

New 2-arylnaphthalenediols and triol inhibitors of HIV-1 integrase—Discovery of a new polyhydroxylated antiviral agent

, 2010
Cédric Maurin, Cédric Lion, Fabrice Bailly, Nadia Touati, Hervé Vezin, Gladys Mbemba, Jean François Mouscadet, Zeger Debyser, Myriam Witvrouw, Philippe Cotelle   +9 more
openalex   +2 more sources

Characterization of transmitted drug resistance among recently infected HIV-1 men who have sex with men in Hebei Province, China. [PDF]

Sci Rep
Lu X, Dong S, Ma L, An N, Bai G, Liu M, Xu X, Wang Y, Li Y, Li Q.   +9 more
europepmc   +1 more source

Specific Inhibition of Human Immunodeficiency Virus Type 1 (HIV-1) Integration in Cell Culture: Putative Inhibitors of HIV-1 Integrase

, 2001
Nick Vandegraaff, Raman Kumar, Helen Hocking, Terrence R. Burke, John Mills, David Rhodes, Christopher J. Burrell, Peng Li   +7 more
openalex   +1 more source

Emergence of Acquired HIV Drug Resistance Among Individuals Receiving Dolutegravir-Based Antiretroviral Therapy in Uganda: A National Laboratory-Based Survey 2023. [PDF]

Open Forum Infect Dis
Asio JN, Watera C, Namayanja G, da Silva JF, Pals S, Ssemwanga D, Sanyu G, Nannyonjo M, Kaganda UK, Busobozi R, Nansumba H, Nabukenya M, Ayitewala A, Ssali M, Katureebe C, Magongo EN, Balidawa H, Nazziwa E, Ntale J, Raizes E, Zheng DP, Zeh C, Hackett S, Naluguza M, Mbidde EK, Kaleebu P.   +25 more
europepmc   +1 more source

Pan-Resistant HIV-1 Drug Resistance Among Highly Treated Patients with Virological Failure on Dolutegravir-Based Antiretroviral Therapy in Zimbabwe. [PDF]

Viruses
Washaya T, Chimukangara B, Mayini J, Bote S, Chin'ombe N, Munyati S, Manasa J.   +6 more
europepmc   +1 more source

Design and Evaluation of Next-Generation HIV Genotyping for Detection of Resistance Mutations to 28 Antiretroviral Drugs Across 5 Major Classes Including Lenacapavir. [PDF]

Clin Infect Dis
Park SY, Takayama C, Ryu J, Sattah M, Badii Z, Kim JW, Shafer RW, Gorbach PM, Lee HY.   +8 more
europepmc   +1 more source

Retrointegration2023-Papers from the 7th International Conference on Retroviral Integration. [PDF]

Viruses
Engelman AN, Grandgenett DP, Maertens GN, Yoder KE, Kvaratskhelia M.   +4 more
europepmc   +1 more source